Page last updated: 2024-08-24

fluorodeoxyglucose f18 and abexinostat

fluorodeoxyglucose f18 has been researched along with abexinostat in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blaise, D; Bouabdallah, R; Broussais, F; Charrier, N; Coso, D; El Cheikh, J; Granata, A; Saillard, C; Schiano, JM	1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and abexinostat

Article	Year
Histone deacetylase inhibitor abexinostat (S78454/PCI-24781) as a successful approach in a case of refractory peripheral angio-immunoblastic T-cell lymphoma, as a bridge to reduced intensity conditioning haplo-identical allogenic stem cell transplant. Leukemia & lymphoma, 2016, Volume: 57, Issue:3 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzofurans; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lymphoma, T-Cell, Peripheral; Positron Emission Tomography Computed Tomography; Recurrence; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome	2016

Article

Year

Histone deacetylase inhibitor abexinostat (S78454/PCI-24781) as a successful approach in a case of refractory peripheral angio-immunoblastic T-cell lymphoma, as a bridge to reduced intensity conditioning haplo-identical allogenic stem cell transplant.

Leukemia & lymphoma, 2016, Volume: 57, Issue:3

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzofurans; Female; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lymphoma, T-Cell, Peripheral; Positron Emission Tomography Computed Tomography; Recurrence; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome

2016